1. Thailand Stocks

  2. •

    Distribution services

  3. •

    Medical distributors
Business Alignment Public Co. Ltd.

Business Alignment Public Co. Ltd.

6.05
THB
0.00
(0.00%)
0.73EPS
7.91P/E
3.45BMarket Cap
Business Alignment Public Co. Ltd.
SET:BIZ.R
(Stock Exchange of Thailand)

Recent

price

6.05

P/E

ratio

7.91

div

yld

8.24%

ROIC.AI

2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
THB
0.52
1.6
1.03
1.1
1.21
1.26
4.87
2.04
2.77
2.83
3.38
4.13
Revenue per Share
0.03
0.15
0.07
0.13
0.15
0.07
0.7
0.22
0.33
0.37
0.51
0.73
Basic EPS, GAAP
-0.25
- -
0.38
-0.24
-0.26
0.32
0.72
0.36
1.05
-0.12
-0.42
0.31
Free Cash Flow per Basic Share
- -
0.47
0.07
0.05
0.11
0.17
0.27
0.28
0.2
0.3
0.35
0.5
Dividend per Share
0.4
0.85
0.85
0.94
0.98
0.89
1.32
1.25
1.39
1.46
1.62
1.44
Book Value per Share
0.4
0.85
0.85
0.94
0.98
0.89
1.32
1.25
1.38
1.46
1.62
1.44
Tangible Book Value per Share
600
462
600
600
600
600
600
600
610
606
599
602
Basic Weighted Avg Shares
311
738
617
659
725
755
2,921
1,226
1,689
1,714
2,024
2,485
Sales/Revenue/Turnover
9.92
11.61
8.31
15.12
15.9
11.45
18.61
14.32
15.22
16.77
19.44
21.61
Operating Margin (%)
1
1
2
2
8
21
20
23
20
20
19
19
Depreciation Expense
21
70
41
81
91
44
420
133
201
224
306
438
Net Income, GAAP
20.49
16.08
20.02
21.23
25.64
37.89
20.49
21
19.94
19.58
19.67
19.49
Effective Tax Rate (%)
6.7
9.52
6.67
12.24
12.62
5.88
14.39
10.89
11.91
13.08
15.1
17.61
Profit Margin (%)
234
511
489
428
458
417
678
551
677
630
772
642
Working Capital
- -
- -
- -
- -
230
250
238
97
96
134
96
66
LT Debt
239
511
513
630
644
575
841
821
902
947
1,044
939
Total Equity
- -
18.81
7.99
13.61
9.63
3.87
37.32
12.35
19.87
20.89
23.48
35.31
Return on Invested Capital (%)
- -
19.7
8.25
14.64
12.16
6.57
38.48
13.01
20.05
21.65
24.74
35.75
Return on Capital (%)
- -
18.72
8.04
15
15.92
7.93
63.42
17.26
25.36
26.18
33
55.02
Return on Common Equity (%)

Capital Structure

THB

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
267
175
277
LT Borrowings
91
74
61
LT Finance Leases
5
5
4
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
601
601
601
Market Capitalization
2,391
2,787
3,454

Working Capital

THB

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
1,457
1,529
1,368
Cash, Cash Equivalents & STI
166
698
154
Accounts Receivable, Net
543
197
545
Inventories
542
447
443
Total Current Liabilities
685
671
726
Payables & Accruals
178
479
431
ST Debt
267
175
277
Deferred Revenue
221
- -
- -

Growth Rates

THB

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
19.73%
13.83%
10.22%
Free Cash Flow
-2,718.73%
81.01%
246.24%
Net Income, GAAP
113.12%
175.38%
36.3%
Sales/Revenue/Turnover
42.83%
57.2%
18.08%
Total Cash Common Dividend
- -
20.78%
16.66%

Quarterly Revenue

THB

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
278
243
674
520
1,714
2025
186
419
1,002
416
2,024
2026
528
538
- -
- -
- -

Quarterly Earnings Per Share

THB

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.06
0.05
0.14
0.13
0.37
2025
0.02
0.08
0.33
0.09
0.51
2026
0.17
0.14
- -
- -
- -

Quarterly Dividends Per Share

THB

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
0.33
- -
- -
0.3
2025
- -
0.37
- -
- -
0.35
2026
- -
0.49
- -
- -
- -
Similar Companies
DataMeds AI, Inc. (NASDAQ:MEDS)
Selcuk Ecza Deposu Ticaret ve Sanayi A.S. (BIST:SELEC)
McKesson Corporation (NYSE:MCK)
Ibnsina Pharma (EGX:ISPH)
Cardinal Health, Inc. (NYSE:CAH)
Entero Healthcare Solutions Limited (NSE:ENTERO)
Business
Business Alignment Public Company Limited (BIZ.BK), founded in 2000 and headquartered in Bangkok, Thailand, serves as a distributor, installer and solution provider of advanced medical equipment and software primarily for cancer treatment through radiotherapy; its core offerings include Linear Accelerators and other treatment delivery systems from exclusive partner Varian Medical Systems Inc., treatment planning systems, oncology information systems, quality assurance software, and complementary equipment from suppliers such as IBA Dosimetry GmbH, Thermo Fisher Scientific Inc., Xstrahl Limited, Vision RT Ltd., and others; the company also provides installation services encompassing radiation room construction and upgrades, after-sales maintenance, repair, and efficiency enhancement services, alongside operation of specialized cancer treatment hospitals offering medical services, hospital rooms, medicines, and supplies, as well as BIZGENES genetic testing kits for lifestyle customization, disease risk prediction including cancer and hereditary conditions, family planning assessments like Thalassemia detection, and medication response analysis. BIZ primarily targets university-affiliated hospitals, cancer hospitals under Thailand's Department of Medical Services, other government hospitals, healthcare agencies, and private hospitals, with operations focused in Thailand. In recent developments, the company secured new projects worth 590 million baht as of March 2025 and reported 2024 profit of 224 million baht with an outstanding dividend payout, reflecting sustained revenue growth in its medical equipment sales and hospital operations segments amid ongoing demand for cancer treatment technologies.